VLDL receptor mediates the uptake of human chylomicron remnants in vitro

Journal of Lipid Research

Volumn 37, Issue 8, 1996, Pages 1733-1742

  Niemeier, Andreas ^a   Gåfvels, Mats ^b   Heeren, Jörg ^a   Meyer, Nicolette ^a   Angelin, Bo ^b   Beisiegel, Ulrike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

apolipoprotein E; lipoprotein lipase

Indexed keywords

APOLIPOPROTEIN E; CHYLOMICRON; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; RECEPTOR PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ADIPOSE TISSUE; ADRENAL GLAND; ANIMAL CELL; ARTICLE; CELL TRANSPORT; CHO CELL; CONTROLLED STUDY; HEART; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LIPOPROTEIN METABOLISM; LIVER; MAMMARY GLAND; NONHUMAN; OVARY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TESTIS;

ANIMALS; APOLIPOPROTEINS E; BLOTTING, WESTERN; CARRIER PROTEINS; CHO CELLS; CHYLOMICRONS; CRICETINAE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; IODINE RADIOISOTOPES; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; LIGANDS; LIPOPROTEIN LIPASE; LIPOPROTEINS, VLDL; MEMBRANE PROTEINS; RABBITS; RECEPTORS, LDL; RECOMBINANT PROTEINS;

EID: 0029831873     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Takahashi, S., Y. Kawarabayasi, T. Nakai, J. Sakai, and T. Yamamoto. 1992. Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc. Natl. Acad. Sci. USA. 89: 9252-9256.
2. Gåfvels, M. E., M. Caird, D. Britt, C. L. Jackson, D. Patterson, and J. F. Strauss, 3d. 1993. Cloning of a cDNA encoding a putative human very low density lipoprotein/apolipoprotein E receptor and assignment of the gene to chromosome 9pter-p23. Somat. Cell Mol. Genet. 19: 557-569.
3. Sakai, J., A. Hoshino, S. Takahashi, Y. Miura, H. Ishii, H. Suzuki, Y. Kawarabayasi, and T. Yamamoto. 1994. Structure, chromosome location, and expression of the human very low density lipoprotein receptor gene. J. Biol. Chem. 269: 2173-2182.
4. Gåfvels, M. E., L. G. Paavola, C. O. Boyd, P. M. Nolan, F. Wittmaack, A. Chawla, M. A. Lazar, M. Bucan, B. Angelin, and J. F. Strauss. 1994. Cloning of a complementary deoxyribonuceic acid encoding the murine homolog of the very low density lipoprotein/apoE receptor: expression pattern and assignment of the gene to mouse chromosome 19. Endocrinology. 135: 387-394.
5. Oka, K., K. Ishimura Oka, M. J. Chu, M. Sullivan, J. Krushkal, W. H. Li, and L. Chan. 1994. Mouse very-low-density-lipoprotein receptor (VLDLR) cDNA cloning, tissue-specific expression and evolutionary relationship with the low-density-lipoprotein receptor. Eur. J. Biochem. 224: 975-982.
6. Bujo, H., M. Hermann, M. O. Kaderli, L. Jacobsen, S. Sugawara, J. Nimpf, T. Yamamoto, and W. J. Schneider. 1994. Chicken oocyte growth is mediated by an eight ligand binding repeat member of the LDL receptor family. EMBO J. 13: 5165-5175.
7. Bujo, H., T. Yamamoto, K. Hayashi, M. Hermann, J. Nimpf, and W. J. Schneider. 1995. Mutant oocytic low density lipoprotein receptor gene family member causes atherosclerosis and female sterility. Proc. Natl. Acad. Sci. USA. 92: 9905-9909.
8. Jingami, H., and T. Yamamoto. 1995. The VLDL receptor: wayward brother of the LDL receptor [see comments]. Curr. Opin. Lipidol. 6: 104-108.
9. Masuzaki, H., H. Jingami, T. Yamamoto, and K. Nakao. 1994. Effects of estradiol on very low density lipoprotein receptor mRNA levels in rabbit heart. FEBS Lett. 347: 211-214.
10. Jokinen, E. V., K. T. Landschulz, K. L. Wyne, Y. K. Ho, P. K. Frykman, and H. H. Hobbs. 1994. Regulation of the very low density lipoprotein receptor by thyroid hormone in rat skeletal muscle. J. Biol. Chem. 269: 26411-26418.
11. Okuizumi, K., O. Onodera, Y. Namba, K. Ikea, T. Yamamoto, K. Seki, A. Ueki, S. Nanko, H. Tanaka, H. Takahashi, K. Oyanagi, H. Mizusawa, I. Kanazawa, and S. Tsuji. 1995. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimers disease. Nat. Genet. 11: 207-209.
12. Moestrup, S. K., and J. Gliemann. 1991. Analysis of ligand recognition by the purified α2-macroglobulin receptor (low density lipoprotein receptor-related protein). J. Biol. Chem. 266: 14011-14017.
13. Herz, J., J. L. Goldstein, D. K. Strickland, Y. K. Ho, and M. S. Brown. 1991. The 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/α2-macroglobulin receptor. J. Biol. Chem. 266: 21232-21238.
14. Kounnas, M. Z., W. S. Argraves, and D. K. Strickland. 1992. The 39-kDa receptor-associated protein interacts with two members of the low density lipoprotein receptor family, alpha 2-macroglobulin receptor and glycoprotein 330. J. Biol. Chem. 267: 21162-21166.
15. Mokuno, H., S. Brady, L. Kotite, J. Herz, and R. J. Havel. 1994. Effect of the 39-kDa receptor-associated protein on the hepatic uptake and endocytosis of chylomicron remnants and low density lipoproteins in the rat. J. Biol. Chem. 269: 13238-13243.
16. Willnow, T. E., Z. Sheng, S. Ishibashi, and J. Herz. 1994. Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist. Science. 264: 1471-1474.
17. r 40,000 receptor associated protein. FEBS Lett. 354: 279-283.
18. Battey, F. D., M. E. Gåfvels, D. J. FitzGerald, W. S. Argraves, D. A. Chappell, J. F. Strauss, and D. K. Strickland. 1994. The 39-kDa receptor-associated protein regulates ligand binding by the very low density lipoprotein receptor. J. Biol. Chem. 269: 23268-23273.
19. Takahashi, S., J. Suzuki, M. Kohno, K. Oida, T. Tamai, S. Miyabo, T. Yamamoto, and T. Nakai. 1995. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase. J. Biol. Chem. 270: 15747-15754.
20. Heegaard, C. W., A. C. Simonsen, K. Oka, L. Kjoller, A. Christensen, B. Madsen, L. Ellgaard, L. Chan, and P. A. Andreasen. 1995. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex. J. Biol. Chem. 270: 20855-20861.
21. Argraves, K. M., F. D. Battey, C. D. MacCalman, K. R. McCrae, M. E. Gåfvels, K. F. Kozarsky, D. A. Chappell, J. F. Strauss, and D. K. Strickland. 1995. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes. J. Biol. Chem. 270: 26550-26557.
22. Yamamoto, T., S. Takahashi, J. Sakai, and Y. Kawarabayasi. 1993. The very low density lipoprotein receptor. Trends Cardiovasc. Med. 3: 144-148.
23. Redgrave, T. G. 1970. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. J. Clin. Invest. 49: 465-471.
24. Camps, L., M. Reina, M. Llobera, S. Vilaro, and T. Olivecrona. 1990. Lipoprotein lipase: cellular origin and functional distribution. Am. J. Physiol. 258: C673-C681.
25. Cooper, A. D. 1977. The metabolism of chylomicron remnants by isolated perfused rat liver. Biochim. Biophys. Acta. 488: 464-474.
26. Sherrill, B. C., T. L. Innerarity, and R. W. Mahley. 1980. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. J. Biol. Chem. 255: 1804-1807.
27. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
28. Windler, E., Y. S. Chao, and R. J. Havel. 1980. Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. J. Biol. Chem. 255: 8303-8307.
29. Shimano, H., Y. Namba, J. Ohsuga, M. Kawamura, K. Yamamoto, M. Shimada, T. Gotoda, K. Harada, Y. Yazaki, and N. Yamada. 1994. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J. Clin. Invest. 93: 2215-2223.
30. Felts, J. M., H. Itakura, and J. C. Crave. 1975. The mechanisms of assimilation of constituents of chylomicrons, very low density lipoproteins and remnants - a new theory. Biochem. Biophys. Res. Commun. 66: 1467-1475.
31. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
32. Chappel, D. A., G. L. Fry, M. A. Waknitz, P. H. Iverius, S. E. Williams, and D. K. Strickland. 1992. The low density lipoprotein receptor-related protein/α2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J. Biol. Chem. 267: 25764-25767.
33. Beisiegel, U., A. Krapp, W. Weber, and G. Olivecrona. 1994. The role of alpha 2M receptor/LRP in chylomicron remnant metabolism. Ann. NY Acad. Sci. 737: 53-69.
34. Diard, P., M. I. Malewiak, D. Lagrange, and S. Griglio. 1994. Hepatic lipase may act as a ligand in the uptake of artificial chylomicron remnant-like particles by isolated rat hepatocytes. Biochem. J. 299: 889-894.
35. Kounnas, M. Z., D. A. Chappell, H. Wong, W. S. Argraves, and D. K. Strickland. 1995. The cellular internalization and degradation of hepatic lipase is mediated by low density lipoprotein receptor-related protein and requires cell surface proteoglycans. J. Biol. Chem. 270: 9307-9312.
36. Krapp, A., S. Ahle, S. Kersting, Y. Hua, K. Kneser, M. Nielsen, J. Gliemann, and U. Beisiegel. 1996. Hepatic lipase mediates the uptake of chylomicrons and β-VLDL into cells via the LDL receptor-related protein (LRP). J. Lipid Res. 37: 926-936.
37. Hussain, M. M., R. W. Mahley, J. K. Boyles, M. Fainaru, W. J. Brecht, and P. A. Lindquist. 1989. Chylomicron-chylomicron remnant clearance by liver and bone marrow in rabbits. Factors that modify tissue-specific uptake. J. Biol. Chem. 264: 9571-9582.
38. Goldberg, I. J., J. J. Kandel, C. B. Blum, and H. N. Ginsberg. 1986. Association of plasma lipoproteins with postheparin lipase activities. J. Clin. Invest. 78: 1523-1528.
39. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
40. Rudling, M., G. Norstedt, H. Olivecrona, E. Reihner, J. A. Gustafsson, and B. Angelin. 1992. Importance of growth hormone for the induction of hepatic low density lipoprotein receptors. Prof. Natl. Acad. Sci. USA. 89: 6983-6987.
41. McFarlane, A. S. 1958. Efficient trace labeling of proteins with iodine. Nature. 182: 53-57.
42. Beil, F. U., S. S. Fojo, H. B. Brewer, Jr., H. Greten, and U. Beisiegel. 1992. Apolipoprotein C-II deficiency syndrome due to apo C-IIHamburg: clinical and biochemical features and HphI restriction enzyme polymorphism. Eur. J. Clin. Invest. 22: 88-95.
43. Hadvary, P., W. Siedler, W. Meister, W. Vetter, and H. Wolfer. 1996. The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active serine of pancreatic lipase. J. Biol. Chem. 266: 2021-2027.
44. Redgrave, T. G., D. C. K. Raberts, and C. E. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
45. Neville, D. M. 1971. Molecular weight determination of protein dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J. Biol. Chem. 246: 6328-6334.
46. Bengtsson-Olivecrona, G., and T. Olivecrona. 1991. Phospholipase activity of milk lipoprotein lipase. Methods Enzymol. 197: 345-356.
47. Nykjaer, A., C. M. Petersen, B. Moeller, P. H. Jensen, S. K. Moestrup, T. L. Holtet, M. Etzerodt, H. C. Thoegersen, M. Munch, P. A. Andreasen, and J. Gliemann. 1992. Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem. 267: 14543-14546.
48. Lönnqvist, F., A. Thörne, K. Nilsell, J. Hoffstedt, and P. Arner. 1995. A pathogenic role of visceral fat 3-adrenoreceptors in obesity. J. Clin. Invest. 95: 1109-1116.
49. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
50. Hussain, M. M., T. L. Innerarity, W. J. Brecht, and R. W. Mahley. 1995. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway. J. Biol. Chem. 270: 8578-8587.
51. Frykman, P. K., M. S. Brown, T. Yamamoto, J. L. Goldstein, and J. Herz. 1995. Normal plasma lipoproteins and fertility in gene-targeted mice homozygous for a disruption in the gene encoding very low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA. 92: 8453-8457.
52. Multhaupt, H. A. B., H. Jin, C. Arenas-Elliot, J. F. Strauss, M. E. Gåfvels, M. J. Warhol, and K. R. McCrae. 1994. Expression of human VLDL receptor mRNA in vascular tissue. Circulation. 90: I-2,6.
53. Wyne, K. L., R. K. Pathak, M. C. Seabra, and H. H. Hobbs. 1996. Expression of the VLDL receptor in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 16: 407-415.
54. Herz, J., and T. E. Willnow. 1995. Lipoprotein and receptor interactions in vivo. Curr. Opin. Lipidol. 6: 97-103.
55. Beisiegel, U., W. Weber, J. R. Havinga, G. Ihrke, D. Y. Hui, M. E. Wernette Hammond, C. W. Turck, T. L. Innerarity, and R. W. Mahley. 1988. Apolipoprotein E-binding proteins isolated from dog and human liver. Arteriosclerosis. 8: 288-297.
56. Chen, C. M., M. Al-Haideri, J. F. Presley, F. R. Maxfield, T. Vogel, N. F. Galeano, S. L. Sturley, and R. J. Deckelbaum. 1995. Apoprotein E on model triglyceride-rich particles, in comparison to apoprotein B on LDL, remains relatively intact after cell uptake. Circulation. 92: Suppl. I-691.
57. Beisiegel, U., W. Weber, J. Heeren, and J. Hilpert. 1995. Intracellular consequences of chylomicron uptake. Circulation. 92: Suppl. I-691.